CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 600 enrolled
Drug / intervention
FBP +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03586583
NCT03586583N/ACompleted

A Feature Comparison Study to Evaluate the Modified Processing of Fujifilm's ASPIRE Cristalle With Digital Breast Tomosynthesis Option as Compared to the Original Processing

Fujifilm Medical Systems USA, Inc.·observational·Posted Jul 13, 2018·Updated Sep 21, 2023

In Brief

An observational study evaluating FBP and ISR for Breast Cancer. Completed, enrolled 600 participants across 1 site.

Detailed Summary

The purpose of the feature comparison study is to evaluate general mammographic features in images of the same breast when reconstructed with modified (ISR and DVIIm) processing as compared to the original processing (FBP with EDR and MFP).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJul 13, 2018
Enrollment StartJun 30, 2018
Primary CompletionJun 30, 2018
Study CompletionNov 19, 2018
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 8.0 years ago

Interventions

FBPdevice

Old processing

ISRdevice

New processing